Literature DB >> 15721025

Heterogeneity of cardiovascular risk among smokers is related to degree of carbon monoxide exposure.

Bo Hedblad1, Mats Ogren, Gunnar Engström, Per Wollmer, Lars Janzon.   

Abstract

BACKGROUND: Between smokers matched for daily tobacco consumption there are marked variations of the cardiovascular risk. This follow up of the population based cohort "Men born in 1914" from Malmö, Sweden, explored whether this is accounted for by the levels of carbon monoxide (CO).
METHODS: Three hundred and sixty-five men without history of cardiovascular disease (CVD) were followed over 27 years. Leg artery disease was defined as a systolic ankle-arm pressure ratio (ABPI) below 0.9 in either leg. Incidence of myocardial infarction (MI), stroke and deaths is based on linkage with regional and national registers. The distribution of CO in blood and expired air, respectively, was divided into quartiles.
RESULTS: There was a significant inverse relation between ABPI and CO in blood and expired air. Incidence of CVD events and deaths increased progressively with degree of CO exposure. Men with CO in the top quartile had significantly increased risks of CVD events (RR: 2.2; 95% CI: 1.00-4.6) and cardiovascular deaths (RR: 3.2, CI: 1.2-8.3), adjusted for daily tobacco consumption and other potential confounders.
CONCLUSIONS: In smokers, the prevalence of leg atherosclerosis and incidence of cardiovascular disease is related to the amount of carbon monoxide in blood or expired air.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15721025     DOI: 10.1016/j.atherosclerosis.2004.10.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.

Authors:  Susan Cheng; Asya Lyass; Joseph M Massaro; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

2.  Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.

Authors:  Matthew Nayor; Danielle M Enserro; Alexa S Beiser; Susan Cheng; Charles DeCarli; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2015-12-22       Impact factor: 7.914

3.  Biomarkers of Exposure and Potential Harm in Exclusive Users of Nicotine Pouches and Current, Former, and Never Smokers: Protocol for a Cross-sectional Clinical Study.

Authors:  David Azzopardi; Linsey Ellen Haswell; Justin Frosina; Michael McEwan; Nathan Gale; Jesse Thissen; Filimon Meichanetzidis; George Hardie
Journal:  JMIR Res Protoc       Date:  2022-10-06

Review 4.  Heated tobacco products for smoking cessation and reducing smoking prevalence.

Authors:  Harry Tattan-Birch; Jamie Hartmann-Boyce; Loren Kock; Erikas Simonavicius; Leonie Brose; Sarah Jackson; Lion Shahab; Jamie Brown
Journal:  Cochrane Database Syst Rev       Date:  2022-01-06

5.  Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes.

Authors:  Susan Cheng; Danielle Enserro; Vanessa Xanthakis; Lisa M Sullivan; Joanne M Murabito; Emelia J Benjamin; Joseph F Polak; Christopher J O'Donnell; Philip A Wolf; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2014-02-25       Impact factor: 29.983

Review 6.  Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

7.  Nocturnal blood pressure elevation predicts progression of albuminuria in elderly people with type 2 diabetes.

Authors:  Walter Palmas; Thomas Pickering; Jeanne Teresi; Joseph E Schwartz; Kazuo Eguchi; Lesley Field; Ruth S Weinstock; Steven Shea
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

8.  Association of Exhaled Carbon Monoxide With Ideal Cardiovascular Health, Circulating Biomarkers, and Incidence of Heart Failure in the Framingham Offspring Study.

Authors:  Bradley Tun; Rachel Ehrbar; Meghan Short; Susan Cheng; Ramachandran S Vasan; Vanessa Xanthakis
Journal:  J Am Heart Assoc       Date:  2020-10-26       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.